AI assistant
Sending…
GALECTIN THERAPEUTICS INC — Director's Dealing 2011
May 31, 2011
33422_dirs_2011-05-31_2494cfd8-7e58-4b23-bf2f-7463a0bc0ed8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GALECTIN THERAPEUTICS INC (PRWP.OB)
CIK: 0001133416
Period of Report: 2011-05-26
Reporting Person: TRABER PETER G (Director, CEO and President)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-05-26 | Employee Stock Option (right to buy) | $1.26 | A | 500000 | Disposed | 2021-05-26 | Common Stock (500000) | Direct |
More from GALECTIN THERAPEUTICS INC
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Mar 31
Earnings Release
2026
Mar 31
Annual Report
2026
Mar 31
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Board/Management Information
2026
Mar 17
Director's Dealing
2026
Feb 9
Board/Management Information
2026
Jan 21